State of Wisconsin Investment Board Portfolio holdings
AUM
$40.9B
1-Year Return
24.31%
This Quarter Return
+8.7%
1 Year Return
+24.31%
3 Year Return
+99.94%
5 Year Return
+177.86%
10 Year Return
+427.44%
AUM
$48.3B
AUM Growth
+$1.43B
(+3.1%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-4.05%
Top 10 Holdings %
Top 10 Hldgs %
18.69%
Holding
2,219
New
201
Increased
548
Reduced
910
Closed
160
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$57M |
| 2 |
Meta Platforms (Facebook)
META
|
+$53.9M |
| 3 |
Biogen
BIIB
|
+$48.6M |
| 4 |
AstraZeneca
AZN
|
+$47.2M |
| 5 |
Accenture
ACN
|
+$39.4M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$114M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$111M |
| 3 |
SPDR Bloomberg High Yield Bond ETF
JNK
|
+$92.5M |
| 4 |
Microsoft
MSFT
|
+$81.6M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$73.2M |
Sector Composition
| 1 | Technology | 22.49% |
| 2 | Financials | 14.31% |
| 3 | Healthcare | 13.25% |
| 4 | Consumer Discretionary | 11.35% |
| 5 | Communication Services | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Lexicon Pharmaceuticals
LXRX
$411M
| $705K | ﹤0.01% |
153,700
+99,100
| +182% | +$455K |
|
1577
Akebia Therapeutics
AKBA
$780M
| $704K | ﹤0.01% |
185,734
| – | – |
|
1578
UiPath
PATH
$6.12B
| $704K | ﹤0.01% |
+10,365
| New | +$704K |
|
1579
Valvoline
VVV
$5.11B
| $702K | ﹤0.01% |
21,628
-1,416
| -6% | -$46K |
|
1580
Eagle Materials
EXP
$7.62B
| $698K | ﹤0.01% |
4,911
-322
| -6% | -$45.8K |
|
|
ICPT
1581
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $697K | ﹤0.01% |
34,900
| – | – |
|
1582
Healthcare Realty
HR
$6.43B
| $694K | ﹤0.01% |
25,986
-1,583
| -6% | -$42.3K |
|
1583
NCR Voyix
VYX
$1.77B
| $694K | ﹤0.01% |
24,807
-1,741
| -7% | -$48.7K |
|
1584
Arcutis Biotherapeutics
ARQT
$2.11B
| $690K | ﹤0.01% |
25,300
| – | – |
|
1585
Chemours
CC
$2.48B
| $684K | ﹤0.01% |
19,656
-1,057
| -5% | -$36.8K |
|
1586
Sana Biotechnology
SANA
$841M
| $682K | ﹤0.01% |
+34,700
| New | +$682K |
|
1587
Pegasystems
PEGA
$9.87B
| $678K | ﹤0.01% |
9,738
-262
| -3% | -$18.2K |
|
1588
Herbalife
HLF
$971M
| $676K | ﹤0.01% |
12,824
+1,421
| +12% | +$74.9K |
|
|
ENNVU
1589
DELISTED
ECP Environmental Growth Opportunities Corp. Unit
ENNVU
| $676K | ﹤0.01% |
66,895
+100
| +0.1% | +$1.01K |
|
1590
Exelixis
EXEL
$10.5B
| $674K | ﹤0.01% |
36,966
-2,021
| -5% | -$36.8K |
|
|
CLVS
1591
DELISTED
Clovis Oncology, Inc.
CLVS
| $669K | ﹤0.01% |
115,282
| – | – |
|
1592
Ionis Pharmaceuticals
IONS
$10.2B
| $668K | ﹤0.01% |
16,749
-55,456
| -77% | -$2.21M |
|
|
FL
1593
DELISTED
Foot Locker
FL
| $667K | ﹤0.01% |
10,823
-2,399
| -18% | -$148K |
|
1594
Ralph Lauren
RL
$19B
| $666K | ﹤0.01% |
5,654
-317
| -5% | -$37.3K |
|
1595
Acadia Healthcare
ACHC
$2.01B
| $663K | ﹤0.01% |
10,561
-583
| -5% | -$36.6K |
|
|
NATI
1596
DELISTED
National Instruments Corp
NATI
| $662K | ﹤0.01% |
15,668
-676
| -4% | -$28.6K |
|
1597
BioAtla
BCAB
$48.1M
| $661K | ﹤0.01% |
15,600
| – | – |
|
1598
Vontier
VNT
$6.28B
| $661K | ﹤0.01% |
20,276
+831
| +4% | +$27.1K |
|
|
NGM
1599
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $661K | ﹤0.01% |
33,500
| – | – |
|
1600
BWX Technologies
BWXT
$15.5B
| $659K | ﹤0.01% |
11,345
-721
| -6% | -$41.9K |
|